{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:15:58Z","timestamp":1791296158371,"version":"4.1.0"},"reference-count":266,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"vor","delay-in-days":366,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1110310"],"award-info":[{"award-number":["1110310"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1150186"],"award-info":[{"award-number":["1150186"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1110455"],"award-info":[{"award-number":["1110455"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1150327"],"award-info":[{"award-number":["1150327"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002848","name":"Comisi\u00f3n Nacional de Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["12\/2007"],"award-info":[{"award-number":["12\/2007"]}],"id":[{"id":"10.13039\/501100002848","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondo Nacional de Desarrollo de Areas Prioritarias","award":["15090007"],"award-info":[{"award-number":["15090007"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.bbadis.2015.05.015","type":"journal-article","created":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T15:20:18Z","timestamp":1432912818000},"page":"1765-1778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":268,"title":["Recent insights on the role of cholesterol in non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"1852","author":[{"given":"Graciela","family":"Arguello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Balboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Arrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Zanlungo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2015.05.015_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40265-012-0004-0","article-title":"Nonalcoholic fatty liver disease: current issues and novel treatment approaches","volume":"73","author":"Lomonaco","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrgastro.2010.21","article-title":"Pathology of nonalcoholic fatty liver disease","volume":"7","author":"Brunt","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0015","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0020","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1478-3231.2008.01823.x","article-title":"Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics","volume":"29","author":"Riquelme","year":"2009","journal-title":"Liver Int."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0025","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1381\/0960892055002347","article-title":"Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass","volume":"15","author":"Boza","year":"2005","journal-title":"Obes. Surg."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0030","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1478-3231.2011.02623.x","article-title":"Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease","volume":"32","author":"Machado","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0035","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/0884533612470464","article-title":"Nonalcoholic fatty liver disease and the metabolic syndrome: clinical implications and treatment","volume":"28","author":"Rahimi","year":"2013","journal-title":"Nutr. Clin. Pract."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0040","doi-asserted-by":"crossref","DOI":"10.1089\/met.2015.1502","article-title":"A perspective on metabolic syndrome and nonalcoholic fatty liver disease","author":"Targher","year":"2015","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0045","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0050","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1053\/j.gastro.2011.06.061","article-title":"Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States","volume":"141","author":"Charlton","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0055","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0060","doi-asserted-by":"crossref","first-page":"5250","DOI":"10.2174\/13816128113199990344","article-title":"Pathophysiology of NASH: perspectives for a targeted treatment","volume":"19","author":"Marra","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"Suppl. 2","key":"10.1016\/j.bbadis.2015.05.015_bb0065","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1440-1746.2011.07018.x","article-title":"Pathophysiology guided treatment of nonalcoholic steatohepatitis","volume":"27","author":"Nguyen","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0070","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jhep.2015.02.041","article-title":"Current efforts and trends in the treatment of NASH","volume":"62","author":"Ratziu","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0075","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/MOL.0b013e328361633e","article-title":"Emerging role of cellular cholesterol in the pathogenesis of nonalcoholic fatty liver disease","volume":"24","author":"Bashiri","year":"2013","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0080","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.plipres.2012.11.002","article-title":"Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis","volume":"52","author":"Musso","year":"2013","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0085","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0090","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/CCO.0000000000000042","article-title":"Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer","volume":"26","author":"Lade","year":"2014","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0095","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1055\/s-0035-1550065","article-title":"Fibrosis in nonalcoholic Fatty liver disease: mechanisms and clinical implications","volume":"35","author":"Angulo","year":"2015","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11901-014-0224-8","article-title":"Mechanisms of liver injury in non-alcoholic steatohepatitis","volume":"13","author":"Duwaerts","year":"2014","journal-title":"Curr. Hepatol. Rep."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbalip.2009.10.007","article-title":"Fatty liver and lipotoxicity","volume":"1801","author":"Trauner","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0110","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1478-3231.2007.01483.x","article-title":"Current concepts in the pathogenesis of nonalcoholic fatty liver disease","volume":"27","author":"Mendez-Sanchez","year":"2007","journal-title":"Liver Int."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.diabet.2012.11.002","article-title":"Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside","volume":"39","author":"Gariani","year":"2013","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2015.02.018","article-title":"Metabolic syndrome and nonalcoholic fatty liver disease: is insulin resistance the link?","author":"Asrih","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0125","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1471-2288-11-158","article-title":"Selection of the appropriate method for the assessment of insulin resistance","volume":"11","author":"Borai","year":"2011","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0130","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.26672","article-title":"Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes","volume":"59","author":"Birkenfeld","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0135","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/lt.20738","article-title":"Nonalcoholic fatty liver disease and liver transplantation","volume":"12","author":"Angulo","year":"2006","journal-title":"Liver Transpl."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0140","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1464-5491.2012.03732.x","article-title":"Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management","volume":"29","author":"Byrne","year":"2012","journal-title":"Diabet. Med."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0145","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/cphy.c130001","article-title":"Steatosis in the liver","volume":"3","author":"Wang","year":"2013","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0150","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MCO.0b013e32833bed6a","article-title":"Adipose tissue lipolysis","volume":"13","author":"Kolditz","year":"2010","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0155","doi-asserted-by":"crossref","first-page":"R199","DOI":"10.1530\/JME-13-0277","article-title":"Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease","volume":"52","author":"Nielsen","year":"2014","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0160","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S095442241400002X","article-title":"Regulation of adipocyte lipolysis","volume":"27","author":"Fruhbeck","year":"2014","journal-title":"Nutr. Res. Rev."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0165","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.beem.2013.02.005","article-title":"Adipose tissue dysfunction contributes to obesity related metabolic diseases","volume":"27","author":"Bluher","year":"2013","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0170","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrendo.2012.114","article-title":"Adaptive immunity in obesity and insulin resistance","volume":"8","author":"Sell","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0175","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1159\/000360509","article-title":"Adipocyte cell death, fatty liver disease and associated metabolic disorders","volume":"32","author":"Eguchi","year":"2014","journal-title":"Dig. Dis."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0180","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1172\/JCI24930","article-title":"Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease","volume":"115","author":"Tamura","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0185","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0190","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1053\/j.gastro.2006.02.006","article-title":"Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis","volume":"130","author":"Doege","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0195","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/gut.2010.222844","article-title":"Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C","volume":"60","author":"Miquilena-Colina","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0200","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1258\/ebm.2011.011128","article-title":"The emerging roles of fatty acid translocase\/CD36 and the aryl hydrocarbon receptor in fatty liver disease","volume":"236","author":"He","year":"2011","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0205","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/hep.21369","article-title":"Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice","volume":"44","author":"Newberry","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0210","article-title":"De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose","author":"Sanders","year":"2015","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0215","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"issue":"Suppl. 2","key":"10.1016\/j.bbadis.2015.05.015_bb0220","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1463-1326.2010.01275.x","article-title":"Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c","volume":"12","author":"Ferre","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0225","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1002\/hep.26299","article-title":"Dietary fructose in nonalcoholic fatty liver disease","volume":"57","author":"Vos","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0230","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3945\/ajcn.114.086314","article-title":"Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis","volume":"100","author":"Chung","year":"2014","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0235","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/ejcn.2014.8","article-title":"Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials","volume":"68","author":"Chiu","year":"2014","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0240","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3350\/cmh.2013.19.3.210","article-title":"Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis","volume":"19","author":"Koo","year":"2013","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0245","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/j.gastro.2007.11.038","article-title":"Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease","volume":"134","author":"Fabbrini","year":"2008","journal-title":"Gastroenterology"},{"issue":"Suppl. 1","key":"10.1016\/j.bbadis.2015.05.015_bb0250","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/jgh.12212","article-title":"Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches","volume":"28","author":"Schuppan","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0255","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0260","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.3390\/ijms15058591","article-title":"Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation","volume":"15","author":"Peverill","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0265","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcmgh.2014.11.005","article-title":"Death receptor-mediated cell death and proinflammatory signaling in nonalcoholic steatohepatitis","volume":"1","author":"Hirsova","year":"2015","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0270","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11901-014-0227-5","article-title":"Hepatic steatosis and steatohepatitis: are they really two distinct entities?","volume":"13","author":"Fielding","year":"2014","journal-title":"Curr. Hepatol. Rep."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0275","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/apt.12046","article-title":"Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?","volume":"36","author":"Yilmaz","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0280","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/hep.22783","article-title":"Burning hepatic fat: therapeutic potential for liver-specific thyromimetics in the treatment of nonalcoholic fatty liver disease","volume":"49","author":"Arrese","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0285","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.atherosclerosis.2015.01.001","article-title":"A concise review of non-alcoholic fatty liver disease","volume":"239","author":"Than","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0290","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/flgastro-2013-100404","article-title":"Non-alcoholic fatty liver disease: a practical approach to treatment","volume":"5","author":"Dyson","year":"2014","journal-title":"Front. Gastrointest."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0295","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nrgastro.2013.182","article-title":"The genetics of NAFLD","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0300","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1055\/s-0033-1358525","article-title":"PNPLA3-associated steatohepatitis: toward a gene-based classification of fatty liver disease","volume":"33","author":"Krawczyk","year":"2013","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0305","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1038\/ncomms5309","article-title":"TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease","volume":"5","author":"Liu","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0310","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fimmu.2014.00177","article-title":"Role of innate immune response in non-alcoholic fatty liver disease: metabolic complications and therapeutic tools","volume":"5","author":"Meli","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0315","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1053\/j.gastro.2012.09.008","article-title":"Sterile inflammation in the liver","volume":"143","author":"Kubes","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0320","doi-asserted-by":"crossref","first-page":"e1004559","DOI":"10.1371\/journal.ppat.1004559","article-title":"Implication of gut microbiota in nonalcoholic fatty liver disease","volume":"11","author":"Boursier","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0325","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.3748\/wjg.v20.i23.7381","article-title":"Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease","volume":"20","author":"Miura","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0330","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/hep.26081","article-title":"Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice","volume":"57","author":"Miura","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0335","doi-asserted-by":"crossref","DOI":"10.1007\/s00109-014-1170-1","article-title":"NLRP3 inflammasome activation is required for fibrosis development in NAFLD","author":"Wree","year":"2014","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0340","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1159\/000360495","article-title":"The inflammasome in liver injury and non-alcoholic fatty liver disease","volume":"32","author":"Mehal","year":"2014","journal-title":"Dig. Dis."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0345","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/cphy.c120035","article-title":"Hepatic stellate cells and liver fibrosis","volume":"3","author":"Puche","year":"2013","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0350","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","article-title":"Pathobiology of liver fibrosis: a translational success story","volume":"64","author":"Lee","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0355","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/liv.12611","article-title":"Renin angiotensin system and fibrosis in non-alcoholic fatty liver disease","volume":"35","author":"Goh","year":"2014","journal-title":"Liver Int."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0360","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bpg.2011.02.010","article-title":"Fibrosis in alcoholic and nonalcoholic steatohepatitis","volume":"25","author":"Bataller","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0365","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPARalpha action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0370","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrgastro.2012.256","article-title":"Liver fibrosis in 2012: convergent pathways that cause hepatic fibrosis in NASH","volume":"10","author":"Friedman","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0375","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-0035-1550060","article-title":"Emerging and disease-specific mechanisms of hepatic stellate cell activation","volume":"35","author":"Wallace","year":"2015","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0380","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jhep.2015.02.039","article-title":"Hepatic fibrosis: concept to treatment","volume":"62","author":"Trautwein","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0385","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1053\/j.gastro.2006.02.040","article-title":"Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver disease","volume":"130","author":"Goldberg","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0390","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1172\/JCI34275","article-title":"Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice","volume":"118","author":"Postic","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0395","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1055\/s-2000-9385","article-title":"Mechanisms of biliary lipid secretion and their role in lipid homeostasis","volume":"20","author":"Oude Elferink","year":"2000","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0400","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hep.21655","article-title":"Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis","volume":"45","author":"Yamaguchi","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0405","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1750-1172-5-24","article-title":"Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers","volume":"5","author":"Peretti","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0410","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/hep.21788","article-title":"Good fat\/bad fat","volume":"45","author":"McClain","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0415","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1073\/pnas.0630588100","article-title":"Triglyceride accumulation protects against fatty acid-induced lipotoxicity","volume":"100","author":"Listenberger","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0420","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-0028-1091979","article-title":"Abnormalities of lipid metabolism in nonalcoholic fatty liver disease","volume":"28","author":"Cheung","year":"2008","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0425","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1586\/egh.09.32","article-title":"Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal","volume":"3","author":"Alkhouri","year":"2009","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0430","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2012.04.005","article-title":"Role of ceramides in nonalcoholic fatty liver disease","volume":"23","author":"Pagadala","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0435","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/liv.12331","article-title":"Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease","volume":"34","author":"Kurek","year":"2014","journal-title":"Liver Int."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0440","doi-asserted-by":"crossref","first-page":"E561","DOI":"10.1002\/oby.20440","article-title":"Metabolomic signatures in lipid-loaded HepaRGs reveal pathways involved in steatotic progression","volume":"21","author":"Brown","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0445","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jhep.2013.03.033","article-title":"Decoding cell death signals in liver inflammation","volume":"59","author":"Brenner","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0450","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cmet.2012.04.004","article-title":"Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease","volume":"15","author":"Min","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0455","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1665-2681(19)31247-5","article-title":"Kupffer cells: increasingly significant role in nonalcoholic fatty liver disease","volume":"13","author":"Wenfeng","year":"2014","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0460","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0465","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hep.25953","article-title":"Excess cholesterol and fat in the diet: a dangerous liaison for energy expenditure and the liver","volume":"57","author":"Neuschwander-Tetri","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0470","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jhep.2008.12.016","article-title":"Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH","volume":"50","author":"Caballero","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0475","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cmet.2006.07.006","article-title":"Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis","volume":"4","author":"Mari","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0480","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/hep.26604","article-title":"Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice","volume":"59","author":"Tomita","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0485","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/hep.25789","article-title":"Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis","volume":"57","author":"Savard","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0490","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2011.06.040","article-title":"Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis","volume":"141","author":"Van Rooyen","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0495","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jhep.2013.02.024","article-title":"Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome","volume":"59","author":"Van Rooyen","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0500","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jnutbio.2014.11.002","article-title":"Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis","volume":"26","author":"Mells","year":"2015","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0505","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1053\/jhep.2003.50132","article-title":"Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis","volume":"37","author":"Musso","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0510","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/00365520802588133","article-title":"Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol","volume":"44","author":"Yasutake","year":"2009","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0515","first-page":"800","article-title":"Is the control of dietary cholesterol intake sufficiently effective to ameliorate nonalcoholic fatty liver disease?","volume":"16","author":"Enjoji","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0520","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.febslet.2010.01.046","article-title":"Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice","volume":"584","author":"Wouters","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0525","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1440-1746.2010.06560.x","article-title":"Inflammatory stress exacerbates hepatic cholesterol accumulation via increasing cholesterol uptake and de novo synthesis","volume":"26","author":"Zhao","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0530","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1016\/j.febslet.2007.11.023","article-title":"Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome","volume":"581","author":"Deushi","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0535","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2008.01.045","article-title":"Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice","volume":"584","author":"Zheng","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0540","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jhep.2009.05.017","article-title":"Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease","volume":"51","author":"Nozaki","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0545","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1567-5688(15)50007-X","article-title":"The effect of ezetimibe on NAFLD","volume":"17","author":"Averna","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0550","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/MOL.0b013e32834c37ee","article-title":"Cholesterol-lowering therapy for the treatment of nonalcoholic fatty liver disease: an update","volume":"22","author":"Musso","year":"2011","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0555","series-title":"The Liver: Biology and Pathobiology, New York","first-page":"617","article-title":"The metabolism and excretion of cholesterol by the liver","author":"D.J.","year":"1998"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0560","series-title":"Biology and Pathobiology, Oxford","first-page":"271","article-title":"Lipoprotein metabolism and cholesterol balance","author":"Cohen","year":"2009"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0565","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2741\/4216","article-title":"Physiological and pathological implications of cholesterol","volume":"19","author":"Cortes","year":"2014","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0570","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1007\/s00018-012-1247-3","article-title":"Insights into the mechanisms of sterol transport between organelles","volume":"70","author":"Mesmin","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0575","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1478-3231.2009.01972.x","article-title":"Determinants of transhepatic cholesterol flux and their relevance for gallstone formation","volume":"29","author":"Zanlungo","year":"2009","journal-title":"Liver Int."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0580","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/iub.1182","article-title":"The role of signalling in cellular cholesterol homeostasis","volume":"65","author":"Luu","year":"2013","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0585","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1146\/annurev.physiol.68.033104.152158","article-title":"LXRS and FXR: the yin and yang of cholesterol and fat metabolism","volume":"68","author":"Kalaany","year":"2006","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0590","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.tcb.2003.08.007","article-title":"Joe Goldstein and Mike Brown: from cholesterol homeostasis to new paradigms in membrane biology","volume":"13","author":"Anderson","year":"2003","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0595","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile acids: natural ligands for an orphan nuclear receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0600","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0605","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1097-2765(00)80348-2","article-title":"Endogenous bile acids are ligands for the nuclear receptor FXR\/BAR","volume":"3","author":"Wang","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0610","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","article-title":"A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis","volume":"6","author":"Goodwin","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0615","doi-asserted-by":"crossref","first-page":"13493","DOI":"10.3748\/wjg.v20.i37.13493","article-title":"Recent insights into farnesoid X receptor in non-alcoholic fatty liver disease","volume":"20","author":"Xu","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0620","doi-asserted-by":"crossref","first-page":"10918","DOI":"10.1074\/jbc.275.15.10918","article-title":"Farnesoid X receptor responds to bile acids and represses cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription","volume":"275","author":"Chiang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0625","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1053\/jhep.2001.24373","article-title":"Biliary cholesterol hypersecretion in gallstone-susceptible mice is associated with hepatic up-regulation of the high-density lipoprotein receptor SRBI","volume":"33","author":"Fuchs","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0630","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1194\/jlr.M800277-JLR200","article-title":"Hepatic overexpression of cholesteryl ester hydrolase enhances cholesterol elimination and in vivo reverse cholesterol transport","volume":"49","author":"Zhao","year":"2008","journal-title":"J. Lipid Res."},{"issue":"Pt 1","key":"10.1016\/j.bbadis.2015.05.015_bb0635","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1042\/bj3360033","article-title":"Sterol carrier protein 2 participates in hypersecretion of biliary cholesterol during gallstone formation in genetically gallstone-susceptible mice","volume":"336","author":"Fuchs","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0640","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1086\/321294","article-title":"Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively","volume":"69","author":"Lu","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0645","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1074\/jbc.M209525200","article-title":"The farnesoid X-receptor is an essential regulator of cholesterol homeostasis","volume":"278","author":"Lambert","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0650","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1677\/JOE-09-0271","article-title":"Liver X receptor in cholesterol metabolism","volume":"204","author":"Zhao","year":"2010","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0655","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/383728a0","article-title":"An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha","volume":"383","author":"Janowski","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0660","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm3312","article-title":"Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR","volume":"13","author":"Calkin","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0665","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1002\/hep.25929","article-title":"Emerging role of fibroblast growth factors 15\/19 and 21 as metabolic integrators in the liver","volume":"56","author":"Cicione","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0670","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.cmet.2011.03.019","article-title":"FGF15\/19 regulates hepatic glucose metabolism by inhibiting the CREB\u2013PGC\u20131alpha pathway","volume":"13","author":"Potthoff","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0675","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/MOL.0000000000000060","article-title":"Regulation of bile acid homeostasis by the intestinal Diet1\u2013FGF15\/19 axis","volume":"25","author":"Reue","year":"2014","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0680","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2010.05.037","article-title":"Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity","volume":"54","author":"Simonen","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0685","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/S0021-9258(18)89648-X","article-title":"Phosphorylation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase and modulation of its enzymic activity by calcium-activated and phospholipid-dependent protein kinase","volume":"260","author":"Beg","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0690","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/0026-0495(87)90101-6","article-title":"Modulation of the enzymic activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase by multiple kinase systems involving reversible phosphorylation: a review","volume":"36","author":"Beg","year":"1987","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0695","doi-asserted-by":"crossref","first-page":"783976","DOI":"10.1155\/2011\/783976","article-title":"Nonalcoholic fatty liver disease: focus on lipoprotein and lipid deregulation","volume":"2011","author":"Fon Tacer","year":"2011","journal-title":"J. Lipid"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0700","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2008.08.001","article-title":"Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)","volume":"48","author":"Musso","year":"2009","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0705","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1055\/s-0033-1358519","article-title":"Lipoprotein metabolism, dyslipidemia, and nonalcoholic fatty liver disease","volume":"33","author":"Cohen","year":"2013","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0710","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.cgh.2013.08.014","article-title":"Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease","volume":"12","author":"Corey","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0715","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.cgh.2014.10.008","article-title":"Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile","volume":"13","author":"Siddiqui","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0720","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.biochi.2010.04.002","article-title":"Suppression of ABCA1 by unsaturated fatty acids leads to lipid accumulation in HepG2 cells","volume":"92","author":"Yang","year":"2010","journal-title":"Biochimie"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0725","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.biochi.2014.04.010","article-title":"ApoA-I or ABCA1 expression suppresses fatty acid synthesis by reducing 27-hydroxycholesterol levels","volume":"103","author":"Ma","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0730","doi-asserted-by":"crossref","first-page":"28564","DOI":"10.1074\/jbc.M112.360081","article-title":"The ABCG5 ABCG8 sterol transporter opposes the development of fatty liver disease and loss of glycemic control independently of phytosterol accumulation","volume":"287","author":"Su","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0735","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1136\/gut.2003.037689","article-title":"Bile secretory function in the obese Zucker rat: evidence of cholestasis and altered canalicular transport function","volume":"53","author":"Pizarro","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0740","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1067\/msy.2003.234","article-title":"Leptin-resistant obese mice have paradoxically low biliary cholesterol saturation","volume":"134","author":"Tran","year":"2003","journal-title":"Surgery"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0745","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/ATVBAHA.113.302355","article-title":"Acceleration of biliary cholesterol secretion restores glycemic control and alleviates hypertriglyceridemia in obese db\/db mice","volume":"34","author":"Su","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0750","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nm1785","article-title":"Hepatic insulin resistance directly promotes formation of cholesterol gallstones","volume":"14","author":"Biddinger","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0755","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1440-1746.2005.03924.x","article-title":"Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors","volume":"20","author":"Loria","year":"2005","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0760","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3109\/00365521.2014.894119","article-title":"Nonalcoholic fatty liver disease and cholesterol gallstones: which comes first?","volume":"49","author":"Ahmed","year":"2014","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0765","doi-asserted-by":"crossref","first-page":"e92656","DOI":"10.1371\/journal.pone.0092656","article-title":"Rapid development of non-alcoholic steatohepatitis in Psammomys obesus (Israeli sand rat)","volume":"9","author":"Spolding","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0770","doi-asserted-by":"crossref","first-page":"28745","DOI":"10.1074\/jbc.M605815200","article-title":"Insulin regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes: roles of forkhead box O1 and sterol regulatory element-binding protein 1c","volume":"281","author":"Li","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0775","doi-asserted-by":"crossref","first-page":"302847","DOI":"10.1155\/2012\/302847","article-title":"Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic Fatty liver disease","volume":"2012","author":"de Bari","year":"2012","journal-title":"J. Lipid"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0780","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.27678","article-title":"Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases (AASLD) \u2014 Food and Drug Administration (FDA) joint workshop","volume":"61","author":"Sanyal","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0785","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1194\/jlr.M800509-JLR200","article-title":"Differential expression of microRNAs in mouse liver under aberrant energy metabolic status","volume":"50","author":"Li","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0790","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/hep.22569","article-title":"Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression","volume":"48","author":"Cheung","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0795","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.dld.2008.08.008","article-title":"MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease","volume":"41","author":"Jin","year":"2009","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0800","series-title":"MicroRNAs in Nonalcoholic Fatty Liver Disease: Novel Biomarkers and Prognostic Tools During the Transition From Steatosis to Hepatocarcinoma, 2014","first-page":"741465","author":"Gori","year":"2014"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0805","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-0034-1397348","article-title":"Circulating microRNAs: emerging biomarkers of liver disease","volume":"35","author":"Arrese","year":"2015","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0810","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/hep.26088","article-title":"Cholesterol and nonalcoholic fatty liver disease: renewed focus on an old villain","volume":"56","author":"Kerr","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0815","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/labinvest.2010.113","article-title":"Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice","volume":"90","author":"Pogribny","year":"2010","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0820","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nature04303","article-title":"Silencing of microRNAs in vivo with \u2018antagomirs\u2019","volume":"438","author":"Krutzfeldt","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0825","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","article-title":"miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting","volume":"3","author":"Esau","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0830","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3892\/ijmm.2015.2076","article-title":"miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty liver disease by targeting HMGCR","volume":"35","author":"Sun","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0835","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0169-409X(01)00140-5","article-title":"Caveolae and intracellular trafficking of cholesterol","volume":"49","author":"Fielding","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0840","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1365-2362.2010.02459.x","article-title":"Altered distribution of caveolin-1 in early liver steatosis","volume":"41","author":"Mastrodonato","year":"2011","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0845","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1499-3872(13)60099-5","article-title":"Upregulation of caveolin-1 and SR-B1 in mice with non-alcoholic fatty liver disease","volume":"12","author":"Qiu","year":"2013","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"issue":"Suppl. 1","key":"10.1016\/j.bbadis.2015.05.015_bb0850","first-page":"166","article-title":"The unique case of the Niemann\u2013Pick type C cholesterol storage disorder","volume":"12","author":"Klein","year":"2014","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0855","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10545-014-9794-4","article-title":"Complex lipid trafficking in Niemann\u2013Pick disease type C","volume":"38","author":"Vanier","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0860","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/oby.2009.415","article-title":"Decreased Npc1 gene dosage in mice is associated with weight gain","volume":"18","author":"Jelinek","year":"2010","journal-title":"Obesity"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0865","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/hmg\/ddq466","article-title":"Npc1 haploinsufficiency promotes weight gain and metabolic features associated with insulin resistance","volume":"20","author":"Jelinek","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0870","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/ng.301","article-title":"Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations","volume":"41","author":"Meyre","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0875","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/ijo.2012.175","article-title":"Contribution of 24 obesity-associated genetic variants to insulin resistance, pancreatic beta-cell function and type 2 diabetes risk in the French population","volume":"37","author":"Robiou-du-Pont","year":"2013","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0880","doi-asserted-by":"crossref","first-page":"22183","DOI":"10.1074\/jbc.R300003200","article-title":"StAR-related lipid transfer (START) proteins: mediators of intracellular lipid metabolism","volume":"278","author":"Soccio","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0885","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1677\/joe.0.1640247","article-title":"The role of the StAR protein in steroidogenesis: challenges for the future","volume":"164","author":"Stocco","year":"2000","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0890","doi-asserted-by":"crossref","first-page":"8462","DOI":"10.1073\/pnas.94.16.8462","article-title":"MLN64 contains a domain with homology to the steroidogenic acute regulatory protein (StAR) that stimulates steroidogenesis","volume":"94","author":"Watari","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0895","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1074\/jbc.M006279200","article-title":"The steroidogenic acute regulatory protein homolog MLN64, a late endosomal cholesterol-binding protein","volume":"276","author":"Alpy","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0900","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.biocel.2014.01.002","article-title":"The StarD4 subfamily of steroidogenic acute regulatory-related lipid transfer (START) domain proteins: new players in cholesterol metabolism","volume":"49","author":"Calderon-Dominguez","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0905","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/biom2010076","article-title":"Oxysterols and their cellular effectors","volume":"2","author":"Olkkonen","year":"2012","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0910","doi-asserted-by":"crossref","first-page":"13666","DOI":"10.3390\/molecules181113666","article-title":"OSBP-related proteins: liganding by glycerophospholipids opens new insight into their function","volume":"18","author":"Olkkonen","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0915","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1074\/jbc.M705313200","article-title":"OSBP-related protein 8 (ORP8) suppresses ABCA1 expression and cholesterol efflux from macrophages","volume":"283","author":"Yan","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0920","doi-asserted-by":"crossref","first-page":"e21078","DOI":"10.1371\/journal.pone.0021078","article-title":"OSBP-related protein 8 (ORP8) regulates plasma and liver tissue lipid levels and interacts with the nucleoporin Nup62","volume":"6","author":"Zhou","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0925","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ncb2211","article-title":"Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism","volume":"13","author":"Jordan","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0930","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jhep.2014.07.024","article-title":"Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent","volume":"61","author":"Gan","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0935","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1136\/gut.35.11.1509","article-title":"Cell biology of liver endothelial and Kupffer cells","volume":"35","author":"Smedsrod","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0940","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1034\/j.1600-0676.2000.020001066.x","article-title":"Kupffer cell depletion by CI2MDP-liposomes alters hepatic cytokine expression and delays liver regeneration after partial hepatectomy","volume":"20","author":"Meijer","year":"2000","journal-title":"Liver"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0945","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/hep.510250417","article-title":"Kupffer cell depletion abolishes induction of interleukin-10 and permits sustained overexpression of tumor necrosis factor alpha messenger RNA in the regenerating rat liver","volume":"25","author":"Rai","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0950","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1440-1746.2012.07084.x","article-title":"Is impaired Kupffer cell function really important to the pathogenesis of nonalcoholic steatohepatitis?","volume":"27","author":"Ono","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0955","doi-asserted-by":"crossref","first-page":"e34378","DOI":"10.1371\/journal.pone.0034378","article-title":"Internalization of modified lipids by CD36 and SR-A leads to hepatic inflammation and lysosomal cholesterol storage in Kupffer cells","volume":"7","author":"Bieghs","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0960","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jhep.2012.02.028","article-title":"Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis","volume":"57","author":"Leroux","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0965","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.22363","article-title":"Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis","volume":"48","author":"Wouters","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0970","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1194\/jlr.M034876","article-title":"Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis","volume":"54","author":"Ioannou","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0975","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0980","doi-asserted-by":"crossref","first-page":"e11765","DOI":"10.1371\/journal.pone.0011765","article-title":"Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation","volume":"5","author":"Rajamaki","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2015.05.015_bb0985","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0990","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/lt.21436","article-title":"Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C","volume":"14","author":"Carotti","year":"2008","journal-title":"Liver Transpl."},{"key":"10.1016\/j.bbadis.2015.05.015_bb0995","first-page":"225","article-title":"Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study","volume":"109","author":"Carpino","year":"2004","journal-title":"Ital. J. Anat. Embryol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1000","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1053\/j.gastro.2011.09.049","article-title":"A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells","volume":"142","author":"Teratani","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb1005","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2014.03.018","article-title":"Acyl-CoA:cholesterol acyltransferase 1 mediates liver fibrosis by regulating free cholesterol accumulation in hepatic stellate cells","volume":"61","author":"Tomita","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1010","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0968-0004(01)01908-9","article-title":"The glucose-regulated proteins: stress induction and clinical applications","volume":"26","author":"Lee","year":"2001","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1015","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1021\/pr900146t","article-title":"Quantitative proteomic survey of endoplasmic reticulum in mouse liver","volume":"9","author":"Song","year":"2010","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1020","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.cmet.2012.03.007","article-title":"The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling","volume":"15","author":"Fu","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1025","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1172\/JCI0216886","article-title":"Orchestrating the unfolded protein response in health and disease","volume":"110","author":"Kaufman","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1030","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1172\/JCI0216784","article-title":"Translational control in the endoplasmic reticulum stress response","volume":"110","author":"Ron","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1035","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1126\/science.1209038","article-title":"The unfolded protein response: from stress pathway to homeostatic regulation","volume":"334","author":"Walter","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2015.05.015_bb1040","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0092-8674(00)80855-7","article-title":"Tripartite management of unfolded proteins in the endoplasmic reticulum","volume":"101","author":"Mori","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2015.05.015_bb1045","doi-asserted-by":"crossref","first-page":"R518","DOI":"10.1016\/S0960-9822(00)00583-2","article-title":"ER stress response: getting the UPR hand on misfolded proteins","volume":"10","author":"Hampton","year":"2000","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1050","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/ars.2010.3790","article-title":"Endoplasmic reticulum stress and the unfolded protein response in nonalcoholic fatty liver disease","volume":"15","author":"Gentile","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1055","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1053\/j.gastro.2007.10.039","article-title":"Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease","volume":"134","author":"Puri","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb1060","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/hep.24553","article-title":"Dysregulation of the unfolded protein response in db\/db mice with diet-induced steatohepatitis","volume":"54","author":"Rinella","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb1065","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1126\/science.1128294","article-title":"Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes","volume":"313","author":"Ozcan","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2015.05.015_bb1070","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1210\/en.2005-0570","article-title":"Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis","volume":"147","author":"Wang","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb1075","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1172\/JCI32752","article-title":"Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents","volume":"118","author":"Ota","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1080","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1126\/science.1103160","article-title":"Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes","volume":"306","author":"Ozcan","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2015.05.015_bb1085","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11010-013-1694-7","article-title":"Endoplasmic reticulum stress leads to lipid accumulation through upregulation of SREBP-1c in normal hepatic and hepatoma cells","volume":"381","author":"Fang","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1090","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/ncb1035","article-title":"The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages","volume":"5","author":"Feng","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1095","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature04399","article-title":"Role of cholesterol and lipid organization in disease","volume":"438","author":"Maxfield","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2015.05.015_bb1100","doi-asserted-by":"crossref","first-page":"20755","DOI":"10.1074\/jbc.M112.340919","article-title":"Lecithin:cholesterol acyltransferase deficiency protects against cholesterol-induced hepatic endoplasmic reticulum stress in mice","volume":"287","author":"Hager","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1105","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1194\/jlr.M043299","article-title":"Endoplasmic reticulum stress impairs cholesterol efflux and synthesis in hepatic cells","volume":"55","author":"Rohrl","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1110","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1242\/jeb.090738","article-title":"The mitochondrial unfolded protein response, a conserved stress response pathway with implications in health and disease","volume":"217","author":"Jovaisaite","year":"2014","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1115","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.cell.2014.07.039","article-title":"Multilayered genetic and omics dissection of mitochondrial activity in a mouse reference population","volume":"158","author":"Wu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2015.05.015_bb1120","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.taap.2004.10.001","article-title":"Hepatic mitochondrial glutathione: transport and role in disease and toxicity","volume":"204","author":"Fernandez-Checa","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1125","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1053\/gast.2003.50089","article-title":"Acetaldehyde impairs mitochondrial glutathione transport in HepG2 cells through endoplasmic reticulum stress","volume":"124","author":"Lluis","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb1130","doi-asserted-by":"crossref","first-page":"33928","DOI":"10.1074\/jbc.M210943200","article-title":"Cholesterol impairs the adenine nucleotide translocator-mediated mitochondrial permeability transition through altered membrane fluidity","volume":"278","author":"Colell","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1135","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.bbabio.2010.02.010","article-title":"Cholesterol and peroxidized cardiolipin in mitochondrial membrane properties, permeabilization and cell death","volume":"1797","author":"Montero","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2015.05.015_bb1140","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.abb.2007.06.012","article-title":"The voltage dependent anion channel affects mitochondrial cholesterol distribution and function","volume":"466","author":"Campbell","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1145","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10863-008-9138-x","article-title":"Mitochondrial membrane cholesterol, the voltage dependent anion channel (VDAC), and the Warburg effect","volume":"40","author":"Campbell","year":"2008","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1150","doi-asserted-by":"crossref","first-page":"11731","DOI":"10.1074\/jbc.M412898200","article-title":"Altered cholesterol metabolism in Niemann\u2013Pick type C1 mouse brains affects mitochondrial function","volume":"280","author":"Yu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1155","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1053\/jhep.2003.50351","article-title":"Sensitivity of the 2-oxoglutarate carrier to alcohol intake contributes to mitochondrial glutathione depletion","volume":"38","author":"Coll","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb1160","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0016-5085(99)70354-9","article-title":"Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice","volume":"117","author":"Yin","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb1165","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.redox.2014.09.005","article-title":"Mitochondrial cholesterol accumulation in alcoholic liver disease: role of ASMase and endoplasmic reticulum stress","volume":"3","author":"Mar\u00ed","year":"2014","journal-title":"Redox Biology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb1170","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/978-90-481-8622-8_15","article-title":"Mammalian StAR-related lipid transfer (START) domains with specificity for cholesterol: structural conservation and mechanism of reversible binding","volume":"51","author":"Lavigne","year":"2010","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1175","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.3748\/wjg.v13.i22.3071","article-title":"Overexpression of the cholesterol-binding protein MLN64 induces liver damage in the mouse","volume":"13","author":"Tichauer","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1180","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1194\/jlr.M002345","article-title":"MLN64 mediates egress of cholesterol from endosomes to mitochondria in the absence of functional Niemann\u2013Pick Type C1 protein","volume":"51","author":"Charman","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1185","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.bbalip.2014.07.002","article-title":"Intracellular cholesterol transporters and modulation of hepatic lipid metabolism: implications for diabetic dyslipidaemia and steatosis","volume":"1842","author":"Soffientini","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2015.05.015_bb1190","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.24552","article-title":"Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice","volume":"54","author":"Li","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb1195","doi-asserted-by":"crossref","first-page":"738","DOI":"10.4254\/wjh.v6.i10.738","article-title":"Lipid-lowering agents in the management of nonalcoholic fatty liver disease","volume":"6","author":"Tziomalos","year":"2014","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1200","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.dld.2014.07.170","article-title":"The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease","volume":"47","author":"Pastori","year":"2015","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1205","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11883-012-0305-5","article-title":"Statins in nonalcoholic fatty liver disease and steatohepatitis: updated review","volume":"15","author":"Nseir","year":"2013","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1210","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/liv.12033","article-title":"Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats","volume":"33","author":"Okada","year":"2013","journal-title":"Liver Int."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1215","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.dld.2014.04.002","article-title":"Statin therapy is associated with a reduced risk of non-alcoholic fatty liver in overweight individuals","volume":"46","author":"de Keyser","year":"2014","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1220","first-page":"CD008623","article-title":"Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"12","author":"Eslami","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2015.05.006","article-title":"Statin use and nonalcoholic steatohepatitis in at risk individuals","author":"Dongiovanni","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1230","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.2174\/13816128113199990314","article-title":"Ezetimibe therapy for dyslipidemia: an update","volume":"19","author":"Katsiki","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1235","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbrc.2012.04.087","article-title":"Ezetimibe reduces fatty acid quantity in liver and decreased inflammatory cell infiltration and improved NASH in medaka model","volume":"422","author":"Oishi","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1240","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1007\/s00125-014-3192-1","article-title":"Ezetimibe in the balance: can cholesterol-lowering drugs alone be an effective therapy for NAFLD?","volume":"57","author":"Musso","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2015.05.015_bb1245","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s00125-013-3149-9","article-title":"The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial","volume":"57","author":"Takeshita","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2015.05.015_bb1250","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/hep.27647","article-title":"Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)","volume":"61","author":"Loomba","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb1255","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00005344-199601000-00012","article-title":"Effect of feeding psyllium and cholestyramine in combination on low density lipoprotein metabolism and fecal bile acid excretion in hamsters with dietary-induced hypercholesterolemia","volume":"27","author":"Turley","year":"1996","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1260","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2015.04.025","article-title":"Bile acid binding resin improves hepatic insulin sensitivity by reducing cholesterol but not triglyceride levels in the liver","author":"Tagawa","year":"2015","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1265","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.25731","article-title":"Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial","volume":"56","author":"Le","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb1270","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1665-2681(19)30911-1","article-title":"Effects of bile acid sequestration on hepatic steatosis in obese mice","volume":"13","author":"Solis","year":"2013","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1275","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/clpt.2010.2","article-title":"Nuclear receptors, inflammation, and liver disease: insights for cholestatic and fatty liver diseases","volume":"87","author":"Arrese","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1280","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s11883-015-0500-2","article-title":"FXR agonists as therapeutic agents for non-alcoholic fatty liver disease","volume":"17","author":"Carr","year":"2015","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1285","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.drudis.2012.05.012","article-title":"Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis","volume":"17","author":"Adorini","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbadis.2015.05.015_bb1290","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2015.05.015_bb1295","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000282091","article-title":"Bile acids as regulators of hepatic lipid and glucose metabolism","volume":"28","author":"Trauner","year":"2010","journal-title":"Dig. Dis."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1300","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/01.ATV.0000178994.21828.a7","article-title":"The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism","volume":"25","author":"Claudel","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1305","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S1665-2681(19)31286-4","article-title":"Obeticholic acid: expanding the therapeutic landscape of NASH","volume":"14","author":"Arrese","year":"2015","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1310","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/hep.22572","article-title":"Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist","volume":"49","author":"Cable","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb1315","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1210\/en.2012-1937","article-title":"GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(\u2212\/\u2212) mice","volume":"154","author":"Panjwani","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2015.05.015_bb1320","doi-asserted-by":"crossref","first-page":"e49152","DOI":"10.1371\/journal.pone.0049152","article-title":"GLP-1 receptor activation inhibits VLDL production and reverses hepatic steatosis by decreasing hepatic lipogenesis in high-fat-fed APOE*3-Leiden mice","volume":"7","author":"Parlevliet","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2015.05.015_bb1325","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrm3313","article-title":"MicroRNAs in metabolism and metabolic disorders","volume":"13","author":"Rottiers","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2015.05.015_bb1330","doi-asserted-by":"crossref","first-page":"e58394","DOI":"10.1371\/journal.pone.0058394","article-title":"Oral probiotic microcapsule formulation ameliorates non-alcoholic fatty liver disease in Bio F1B Golden Syrian hamsters","volume":"8","author":"Bhathena","year":"2013","journal-title":"PLoS One"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443915001647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443915001647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T02:00:11Z","timestamp":1652148011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443915001647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":266,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0925443915001647"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2015.05.015","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent insights on the role of cholesterol in non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2015.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}